Cargando…
A One-Pot Three-Component Double-Click Method for Synthesis of [(67)Cu]-Labeled Biomolecular Radiotherapeutics
A one-pot three-component double-click process for preparing tumor-targeting agents for cancer radiotherapy is described here. By utilizing DOTA (or NOTA) containing tetrazines and the TCO-substituted aldehyde, the two click reactions, the tetrazine ligation (an inverse electron-demand Diels-Alder c...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432496/ https://www.ncbi.nlm.nih.gov/pubmed/28507297 http://dx.doi.org/10.1038/s41598-017-02123-2 |
_version_ | 1783236638390878208 |
---|---|
author | Fujiki, Katsumasa Yano, Shinya Ito, Takeshi Kumagai, Yuki Murakami, Yoshinori Kamigaito, Osamu Haba, Hiromitsu Tanaka, Katsunori |
author_facet | Fujiki, Katsumasa Yano, Shinya Ito, Takeshi Kumagai, Yuki Murakami, Yoshinori Kamigaito, Osamu Haba, Hiromitsu Tanaka, Katsunori |
author_sort | Fujiki, Katsumasa |
collection | PubMed |
description | A one-pot three-component double-click process for preparing tumor-targeting agents for cancer radiotherapy is described here. By utilizing DOTA (or NOTA) containing tetrazines and the TCO-substituted aldehyde, the two click reactions, the tetrazine ligation (an inverse electron-demand Diels-Alder cycloaddition) and the RIKEN click (a rapid 6π-azaelectrocyclization), could simultaneously proceed under mild conditions to afford covalent attachment of the metal chelator DOTA or NOTA to biomolecules such as to albumin and anti-IGSF4 antibody without altering their activities. Subsequently, radiolabeling of DOTA- or NOTA-attached albumin and anti-IGSF4 antibody (an anti-tumor-targeting antibody) with [(67)Cu], a β(−)-emitting radionuclide, could be achieved in a highly efficient manner via a simple chelation with DOTA proving to be a more superior chelator than NOTA. Our work provides a new and operationally simple method for introducing the [(67)Cu] isotope even in large quantities to biomolecules, thereby representing an important process for preparations of clinically relevant tumor-targeting agents for radiotherapy. |
format | Online Article Text |
id | pubmed-5432496 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-54324962017-05-16 A One-Pot Three-Component Double-Click Method for Synthesis of [(67)Cu]-Labeled Biomolecular Radiotherapeutics Fujiki, Katsumasa Yano, Shinya Ito, Takeshi Kumagai, Yuki Murakami, Yoshinori Kamigaito, Osamu Haba, Hiromitsu Tanaka, Katsunori Sci Rep Article A one-pot three-component double-click process for preparing tumor-targeting agents for cancer radiotherapy is described here. By utilizing DOTA (or NOTA) containing tetrazines and the TCO-substituted aldehyde, the two click reactions, the tetrazine ligation (an inverse electron-demand Diels-Alder cycloaddition) and the RIKEN click (a rapid 6π-azaelectrocyclization), could simultaneously proceed under mild conditions to afford covalent attachment of the metal chelator DOTA or NOTA to biomolecules such as to albumin and anti-IGSF4 antibody without altering their activities. Subsequently, radiolabeling of DOTA- or NOTA-attached albumin and anti-IGSF4 antibody (an anti-tumor-targeting antibody) with [(67)Cu], a β(−)-emitting radionuclide, could be achieved in a highly efficient manner via a simple chelation with DOTA proving to be a more superior chelator than NOTA. Our work provides a new and operationally simple method for introducing the [(67)Cu] isotope even in large quantities to biomolecules, thereby representing an important process for preparations of clinically relevant tumor-targeting agents for radiotherapy. Nature Publishing Group UK 2017-05-15 /pmc/articles/PMC5432496/ /pubmed/28507297 http://dx.doi.org/10.1038/s41598-017-02123-2 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Fujiki, Katsumasa Yano, Shinya Ito, Takeshi Kumagai, Yuki Murakami, Yoshinori Kamigaito, Osamu Haba, Hiromitsu Tanaka, Katsunori A One-Pot Three-Component Double-Click Method for Synthesis of [(67)Cu]-Labeled Biomolecular Radiotherapeutics |
title | A One-Pot Three-Component Double-Click Method for Synthesis of [(67)Cu]-Labeled Biomolecular Radiotherapeutics |
title_full | A One-Pot Three-Component Double-Click Method for Synthesis of [(67)Cu]-Labeled Biomolecular Radiotherapeutics |
title_fullStr | A One-Pot Three-Component Double-Click Method for Synthesis of [(67)Cu]-Labeled Biomolecular Radiotherapeutics |
title_full_unstemmed | A One-Pot Three-Component Double-Click Method for Synthesis of [(67)Cu]-Labeled Biomolecular Radiotherapeutics |
title_short | A One-Pot Three-Component Double-Click Method for Synthesis of [(67)Cu]-Labeled Biomolecular Radiotherapeutics |
title_sort | one-pot three-component double-click method for synthesis of [(67)cu]-labeled biomolecular radiotherapeutics |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432496/ https://www.ncbi.nlm.nih.gov/pubmed/28507297 http://dx.doi.org/10.1038/s41598-017-02123-2 |
work_keys_str_mv | AT fujikikatsumasa aonepotthreecomponentdoubleclickmethodforsynthesisof67culabeledbiomolecularradiotherapeutics AT yanoshinya aonepotthreecomponentdoubleclickmethodforsynthesisof67culabeledbiomolecularradiotherapeutics AT itotakeshi aonepotthreecomponentdoubleclickmethodforsynthesisof67culabeledbiomolecularradiotherapeutics AT kumagaiyuki aonepotthreecomponentdoubleclickmethodforsynthesisof67culabeledbiomolecularradiotherapeutics AT murakamiyoshinori aonepotthreecomponentdoubleclickmethodforsynthesisof67culabeledbiomolecularradiotherapeutics AT kamigaitoosamu aonepotthreecomponentdoubleclickmethodforsynthesisof67culabeledbiomolecularradiotherapeutics AT habahiromitsu aonepotthreecomponentdoubleclickmethodforsynthesisof67culabeledbiomolecularradiotherapeutics AT tanakakatsunori aonepotthreecomponentdoubleclickmethodforsynthesisof67culabeledbiomolecularradiotherapeutics AT fujikikatsumasa onepotthreecomponentdoubleclickmethodforsynthesisof67culabeledbiomolecularradiotherapeutics AT yanoshinya onepotthreecomponentdoubleclickmethodforsynthesisof67culabeledbiomolecularradiotherapeutics AT itotakeshi onepotthreecomponentdoubleclickmethodforsynthesisof67culabeledbiomolecularradiotherapeutics AT kumagaiyuki onepotthreecomponentdoubleclickmethodforsynthesisof67culabeledbiomolecularradiotherapeutics AT murakamiyoshinori onepotthreecomponentdoubleclickmethodforsynthesisof67culabeledbiomolecularradiotherapeutics AT kamigaitoosamu onepotthreecomponentdoubleclickmethodforsynthesisof67culabeledbiomolecularradiotherapeutics AT habahiromitsu onepotthreecomponentdoubleclickmethodforsynthesisof67culabeledbiomolecularradiotherapeutics AT tanakakatsunori onepotthreecomponentdoubleclickmethodforsynthesisof67culabeledbiomolecularradiotherapeutics |